Amanda Brink, DNP, APRN, FNP-BC, AOCNP, unpacks a key question: why do liver metastases influence immunotherapy response?
Immunotherapy
Advertisement
The study explored whether existing racial and socioeconomic disparities affect the overall survival of patients with mRCC.
Immune checkpoint inhibitors have increased survival for patients with NSCLC, however side effect-burden remains significant.
It's critical for oncology nurses to understand the implications of recent research on immunotherapy for these patients.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.